000			03817nam a22004095i 4500
001			60411
005			20200226102523.0
007			cr nn 008mamaa
008			170531s2017 gw | s |||| 0|eng d
020			_a9783319546438 _9978-3-319-54643-8
024	7		_a10.1007/978-3-319-54643-8 _2doi
035			_a(DE-He213)978-3-319-54643-8
050		4	_aRC681-688.2
072		7	_aMJD _2bicssc
072		7	_aMED010000 _2bisacsh
082	0	4	_a616.12 _223
245	1	0	_aOral Anticoagulation Therapy _h[electronic resource] : _bCases and Clinical Correlation / _cedited by Kathryn Kiser.
264		1	_aCham : _bSpringer International Publishing : _bImprint: Springer, _c2017.
300			_aX, 313 p. 6 illus., 2 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aAtrial Fibrillation: Basic simple introductory case -- Patient who desires best reduction in ischemic stroke possible -- Elderly patient (e.g. > 80 years old) -- Patient with prior history of GI hemorrhage -- Patient with history of intracranial hemorrhage while on warfarin -- Patient with history of adherence issues who uses pill box -- Patient with stable moderate chronic kidney disease -- Patient with variable renal function -- Patient with concomitant coronary artery disease -- Patient with concomitant history of venous thromboembolism -- Venous Thromboembolism (VTE): Patient with new DVT -- Patient with new PE -- Patient s/p hip replacement -- Patient in ICU in need of DVT prophylaxis -- Patient with VTE and concomitant atherosclerotic disease -- Patient with DVT in ICU with feeding tube -- Patient with moderate chronic kidney disease and VTE -- Patient with recurrent VTE -- Patient with PE who underwent thrombolytic therapy -- Patient s/p knee replacement -- Acute Coronary Syndrome: Patient on a new oral anticoagulant presenting with ACS -- Patient post PCI -- Patient with ACS with additional indication for oral anticoagulant -- Patient with ST segment elevation MI (lytic candidate) on new oral anticoagulant -- Patient with ACS who will be undergoing bypass surgery -- Drug Interactions: CYP 3A4 inhibitors -- PgP inhibitors -- Pharmacodynamic interactions -- Mixed CYP 3A4/PgP inhibitors -- Plausible (but unproven) drug interactions (e.g. cyclosporine) -- Special Populations: Atrial fibrillation ablation -- Mechanical valves -- Coagulopathies -- Pregnancy -- Malignancies -- Perioperative management-minor procedures -- Perioperative management-major procedures.
520			_aThis case-based title reviews anticoagulation management strategies available for a wide variety of clinical scenarios. Designed to aid providers of direct patient care on complex clinical decisions regarding appropriate evidence-based therapy options, patient and agent related variables to consider, as well as expert opinion on the topic.  Oral Anticoagulation Therapy: Cases and Clinical Correlation will provide clinicians and trainees with clear clinical cases, commentary, and resources to develop their knowledge base, problem-solving skills, and ability to practically apply new knowledge to a variety of clinical situations.  Resources provided in cases include valuable figures, tables, and key points designed for the reader to be able to utilize at the point of care.
650		0	_aMedicine.
650		0	_aCardiology.
650	1	4	_aMedicine & Public Health.
650	2	4	_aCardiology.
700	1		_aKiser, Kathryn. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9783319546414
856	4	0	_uhttp://dx.doi.org/10.1007/978-3-319-54643-8
912			_aZDB-2-SME
999			_c6164 _d6164